or Try an Advanced Search...

    Lymphocytic Leukemia Stocks List

    Symbol Grade Name % Change
    GMAB F Genmab A/S 1.00
    CLLS D Cellectis S.A. 7.89
    AFMD D Affimed Therapeutics B.V. -1.26
    EGRX C Eagle Pharmaceuticals, Inc. 5.16
    BIIB C Biogen Idec Inc. -1.84
    LGND B Ligand Pharmaceuticals Incorporated -2.46
    EBS B Emergent Biosolutions, Inc. 0.67
    TEVA B Teva Pharmaceutical Industries 1.63
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
    Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Cancer Biotechnology Drugs Monoclonal Antibodies Monoclonal Antibody Multiple Myeloma Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Biopharmaceutical Blastoma CD19 Cd20

    Related ETFs - A few ETFs which own one or more of the above listed Lymphocytic Leukemia stocks.

    Symbol Grade Name Weight
    ISRA C Market Vectors Israel ETF 9.84
    EIS C iShares MSCI Israel Capped Investable Market Index Fund 9.53
    MNTL B Tema Neuroscience and Mental Health ETF 8.11
    PJP C PowerShares Dynamic Pharmaceuticals 6.86
    FBT B First Trust Amex Biotech Index Fund 6.4
    View all Lymphocytic Leukemia ETFs...
    Compare ETFs
    Compare EIS to PJP Compare MNTL to FBT Compare PJP to FBT

        Lymphocytic Leukemia Stocks Recent News

        Date Stock Title
        Jul 3 BIIB Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
        Jul 3 BIIB Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
        Jul 3 EBS Emergent scores US medical countermeasure contracts worth over $250m
        Jul 3 EBS Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday? (UPDATED)
        Jul 2 TEVA Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
        Jul 2 BIIB Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
        Jul 2 BIIB US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments
        Jul 2 TEVA FTC investigates Teva over contested product patents
        Jul 2 BIIB Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
        Jul 2 EBS Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
        Jul 2 BIIB Biogen Completes Acquisition of Human Immunology Biosciences
        Jul 2 EBS Emergent BioSolutions secures $250M contracts for the U.S. government
        Jul 2 EBS Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
        Jul 1 TEVA Update: Market Chatter: Teva Pharmaceuticals Faces FTC Probe on Patent Listings
        Jul 1 TEVA Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity
        Jul 1 TEVA Teva focus of FTC investigation over inhaler patents
        Jul 1 GMAB AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
        Jul 1 LGND Lifecore Biomedical Announces Cooperation Agreement with 22NW
        Jul 1 BIIB 10 clinical trials to watch in the second half of 2024
        Jun 28 TEVA New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
        Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Cancer Biotechnology Drugs Monoclonal Antibodies Monoclonal Antibody Multiple Myeloma Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Biopharmaceutical Blastoma CD19 Cd20
        Lymphocytic Leukemia

        Lymphocytic leukemia is a type of cancer that affects the white blood cells, or lymphocytes, in the body. It is a type of leukemia, which is a cancer of the blood and bone marrow. In lymphocytic leukemia, the body produces too many abnormal lymphocytes, which can crowd out healthy white blood cells, red blood cells, and platelets. This can lead to anemia, infections, and other serious health problems. Treatment for lymphocytic leukemia typically involves chemotherapy, radiation, and/or stem cell transplant.

        Browse All Tags